Synergistic activity of fenretinide and the Bcl-2 family protein inhibitor ABT-737 against human neuroblastoma.

Synergistic activity of fenretinide and the Bcl-2 family protein inhibitor ABT-737 against human neuroblastoma.

Item
http://www.wikidata.org/entity/Q34323880
Cell-based small-molecule compound screen identifies fenretinide as potential therapeutic for translocation-positive rhabdomyosarcomaThe sensitivity of diffuse large B-cell lymphoma cell lines to histone deacetylase inhibitor-induced apoptosis is modulated by BCL-2 family protein activityA transcriptomic signature mediated by HOXA9 promotes human glioblastoma initiation, aggressiveness and resistance to temozolomideCombination of fenretinide and selenite inhibits proliferation and induces apoptosis in ovarian cancer cells.P450 inhibitor ketoconazole increased the intratumor drug levels and antitumor activity of fenretinide in human neuroblastoma xenograft models.Thymosin-β4 is a determinant of drug sensitivity for Fenretinide and Vorinostat combination therapy in neuroblastoma.Combining a BCL2 inhibitor with the retinoid derivative fenretinide targets melanoma cells including melanoma initiating cellsCaspase-dependent Mcl-1 cleavage and effect of Mcl-1 phosphorylation in ABT-737-induced apoptosis in human acute lymphoblastic leukemia cell lines.Reversal of lung cancer multidrug resistance by pH-responsive micelleplexes mediating co-delivery of siRNA and paclitaxel.RNA interference screening identifies a novel role for autocrine fibroblast growth factor signaling in neuroblastoma chemoresistance.Mitochondrial Bcl-2 family dynamics define therapy response and resistance in neuroblastomaThe Wnt Target Protein Peter Pan Defines a Novel p53-independent Nucleolar Stress-Response Pathway.Mild thermotolerance induced at 40 °C protects cells against hyperthermia-induced pro-apoptotic changes in Bcl-2 family proteins.Understanding sensitivity to BH3 mimetics: ABT-737 as a case study to foresee the complexities of personalized medicine.p53-independent Noxa induction by cisplatin is regulated by ATF3/ATF4 in head and neck squamous cell carcinoma cells.
P2860

Synergistic activity of fenretinide and the Bcl-2 family protein inhibitor ABT-737 against human neuroblastoma.

Item
http://www.wikidata.org/entity/Q34323880
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Synergistic activity of fenret ...... 7 against human neuroblastoma.
@ast
Synergistic activity of fenret ...... 7 against human neuroblastoma.
@en
Synergistic activity of fenret ...... 7 against human neuroblastoma.
@nl
type
label
Synergistic activity of fenret ...... 7 against human neuroblastoma.
@ast
Synergistic activity of fenret ...... 7 against human neuroblastoma.
@en
Synergistic activity of fenret ...... 7 against human neuroblastoma.
@nl
prefLabel
Synergistic activity of fenret ...... 7 against human neuroblastoma.
@ast
Synergistic activity of fenret ...... 7 against human neuroblastoma.
@en
Synergistic activity of fenret ...... 7 against human neuroblastoma.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P932
P356
P1433
P1476
Synergistic activity of fenret ...... 7 against human neuroblastoma.
@en
P2093
P2860
P304
P31
P356
10.1158/1078-0432.CCR-11-0578
P407
P433
P478
P577
P698
P932